Such a downregulation of IGFBP7 by promoter methylation was previously observed in solid tumours including melanoma, prostate, lung and breast cancer as well as T-ALL, suggesting a common mechanism in cancer [19,21,30-32]. This evidence concerns the gene IGFBP7 and breast cancer.